Koliwad Lab Identifies Biomarker for Diabetes Risk

Suneil Koliwad, MD, PhD, and his team have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings – demonstrated initially in mice and supported by data from human patients – could lead to new biomarkers to predict who is at risk and guide treatments to reduce the medical burden of obesity.

Read more here.